Skip to main content
Randall Riggs

Randall Riggs

Amytrx Therapeutics
Randy Riggs is the Chief Business Officer of Amytrx and oversees critical business efforts, including strategy, business development, and finance. With more than 28 years of experience within the pharmaceutical and biotechnology industries, Mr. Riggs has held various roles of increasing responsibility, including with Eli Lilly & Company, Lexicon Genetics, BioCryst Pharmaceuticals and then as President & CEO of Advanced Cancer Therapeutics (ACT) where he led several novel products into clinical development. Mr. Riggs received his Bachelor of Business Administration in Management cum laude from Texas A&M University and his Master’s in Business Administration in Finance from the University of Houston.